Bevacizumab

Indications & Dose:

METASTATIC colorectal cancer with a combinatio either of fluorouracil and folinic acid or of fluorouracil, folinic acid and irinotecan by intravenous infusion. l

• BY INJECTION

Concentrate for intravenous infusion, bevacizumab Administered i/v 30mg/m2 over 6-10 minutes weekly

Contraindications:

pregnancy breastfeeding metastases

Side Effects:

mucocutaneous bleeding; gastrointestinal perforation; impaired wound healing; arterial thromboembolism; hypertension proteinuria

Cautions:

Precautions:

Interaction:

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: